|
Advisory
Committees
Nature and Basis Statements of Conflict(s)
of Interest for Voting Members of FDA Advisory Committee Members
The Agency is revising its procedures
regarding the disclosure of conflicts of interest and waivers for
voting advisory committee members in order to implement the requirements
of section 795 of Pub. L. No. 109-97 (Agriculture, Rural Development,
Food and Drug Administration, and Related Agencies Appropriations
Act, 2006) (Nov. 10, 2005). This information is being provided as
an interim measure to comply with the requirements of this law.
Joint Meeting of the Endocrinologic and
Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management
Advisory Committee
July 30, 2007
Curt
Furberg, M.D.
• 18 U.S.C. 208
waiver [pdf]
• Acknowledgement and Consent [pdf]
Steven
Nissen, M.D.
• 18 U.S.C. 208
waiver [pdf]
• Acknowledgement and Consent [pdf]
Thomas
Pickering, M.D.
• 18 U.S.C. 208
waiver [pdf]
• Acknowledgement and Consent [pdf]
David
Schade, M.D.
• 18 U.S.C. 208
waiver [pdf]
• Acknowledgement and Consent [pdf]
Morris
Schambelan, M.D.
• 18 U.S.C. 208
waiver [pdf]
• Acknowledgement and Consent [pdf]
John
Teerlink, M.D.
• 18 U.S.C. 208
waiver [pdf]
• Acknowledgement and Consent [pdf]
Page updated:
July 9, 2007
|
|